|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
![]() |
Wednesday
AVONEX May Now Be Given With Smaller Needle....PLUS new auto injector on horizon
AVONEX(R) (Interferon beta 1a), the most prescribed MS therapy worldwide may now be administered with a needle that is 20 percent shorter and thinner than the currently approved needle. People living with MS and taking or considering AVONEX may speak with their healthcare provider to see if the smaller needle is appropriate for them. Additionally, a supplemental application has been filed with the U.S. Food and Drug Administration (FDA) to provide a new needle attachment, which will lock onto the syringe to make it easier for patients to know that the needle is firmly attached as well as a proposed change in the room temperature storage recommendations for AVONEX. FDA action on this supplement is expected in the fall. |